Immune-Checkpoint Inhibitors for Metastatic Colorectal Cancer: A Systematic Review of Clinical Outcomes

SIMPLE SUMMARY: In 2018, colorectal cancer (CRC) was declared the fourth most deadly cancer worldwide. Unfortunately, a quarter of all patients are diagnosed at late stages, when curative surgery is not possible, rendering systemic therapy and/or best supportive care as the only options. To our know...

Descripción completa

Detalles Bibliográficos
Autores principales: Shek, Dmitrii, Akhuba, Liia, Carlino, Matteo S., Nagrial, Adnan, Moujaber, Tania, Read, Scott A., Gao, Bo, Ahlenstiel, Golo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Systematic Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8430485/
https://www.ncbi.nlm.nih.gov/pubmed/34503155
http://dx.doi.org/10.3390/cancers13174345

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8430485/
https://www.ncbi.nlm.nih.gov/pubmed/34503155
http://dx.doi.org/10.3390/cancers13174345

Ejemplares similares